important considerations in the management of hr , her2-negative early breast cancer
Published 1 year ago • 5.9K plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
30:49
conceptualizing guidelines to manage patients with hr–positive, her2-negative early breast cancer
-
34:58
management of hr-positive/her2-negative early breast cancer: taking direction from the updated gu...
-
4:45
advances and considerations in the treatment and management of hr , her2-, advanced breast cancer
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
33:11
recent updates in hr-positive/her2-negative early breast cancer: a deep dive into understanding t...
-
28:58
[cancer fight together with oncologists] ep.7 hormone receptor-positive breast cancer
-
18:12
tiến bộ trong điều trị ung thư vú di căn với thuốc ức chế cdk46
-
1:01:03
ep #012 | how marisa peer beat cancer twice with this powerful mental technique
-
7:15
asco 2023 expert report in hr positive, her2 negative breast cancer by catherine harper-wynne
-
0:35
key challenge associated with the management of hr /her2- breast cancer
-
31:59
assessing risk in hormone receptor-positive/her2-negative early breast cancer: how to approach ch...
-
2:14
management of premenopausal hr /her2- breast cancer with micro-metastasis
-
46:25
the role of biomarkers in hr-positive/her2-negative early breast cancer: from clinical analysis t...
-
6:39
expert report on advances in the management of her2-negative and her2-low advanced breast cancer
-
2:24
identifying drivers of first-line hr /her2- metastatic breast cancer treatment choices
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
1:36
an overview of the meribel study in her2-negative breast cancer
-
3:44
alternate: neoadjuvant endocrine treatment in er /her2- breast cancer
-
1:57
impact of cdk4/6 inhibitors on hr-positive, her2-negative advanced breast cancer
-
34:12
new and emerging agents in her2-negative metastatic breast cancer: implications for practice
-
3:06
prognostic score in early hr /her2- breast cancer: rs, factors, mutations, histology
-
7:11
updates on hormone receptor-positive her2-negative breast cancer